Apigenin
CAS 520-36-5
Apigenin (CAS 520-36-5) is a pharmaceutical compound with 11 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 19300.632091836735 nM | 192 | - |
| - | Potency | 21758.139600000002 nM | 155 | - |
| - | GI50 | 27241.293962264153 nM | 53 | - |
| - | MIC | 85.71923076923076 ug.mL-1 | 26 | - |
| - | EC50 | 25646.4 nM | 25 | - |
| - | Ki | 17677.33095238095 nM | 21 | - |
| - | IC50 | 18.583529411764708 ug.mL-1 | 17 | - |
| - | AC50 | 4190.455 nM | 4 | - |
| - | Kd | 13127.5 nM | 4 | - |
| - | EC50 | 6.73 ug.mL-1 | 2 | - |
| - | MIC | 6000 nM | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| CFTR CFTR |
Potentiation | - | - |
| CYP1A1 CYP1A1 |
Inhibition | 6.409999847412109 pKi | 21482471 |
| CYP1B1 CYP1B1 |
Inhibition | 7.190000057220459 pKi | 21482471 |
| acetylcholinesterase (Yt blood group) ACHE |
Inhibition | 7.920000076293945 pIC50 | - |
| transthyretin TTR |
Binding | 6.599999904632568 pKd | 26214366 |
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| APIGENIN | 1368130 | SU | MTHSPL |
| apigenin | 1368130 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Apigenin used for in pharmaceutical contexts?
Apigenin (CAS 520-36-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Apigenin?
No adverse-event association or SIDER side-effect rows are rendered for Apigenin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Apigenin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Apigenin with EU status "permitted".
What clinical phase is Apigenin in?
No phase 1-4 clinical development badge is rendered for Apigenin because the matched compound identifier rows do not contain a max-phase value.